Bluebird Bio

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Bluebird Bio and other ETFs, options, and stocks.

About BLUE

bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases. It also offers ZYNTEGLO or beti-cel and SKYSONA or eli-cel gene therapies.

CEO

Andrew Obenshain

CEOAndrew Obenshain

Employees

248

Employees248

Headquarters

Somerville, Massachusetts

HeadquartersSomerville, Massachusetts

Founded

1992

Founded1992

Employees

248

Employees248

BLUE Key Statistics

Market cap

40.68M

Market cap40.68M

Price-Earnings ratio

-0.17

Price-Earnings ratio-0.17

Dividend yield

—

Dividend yield—

Average volume

175.57K

Average volume175.57K

High today

$4.17

High today$4.17

Low today

$4.02

Low today$4.02

Open price

$4.12

Open price$4.12

Volume

80.50K

Volume80.50K

52 Week high

$28.60

52 Week high$28.60

52 Week low

$3.56

52 Week low$3.56

Bluebird Bio

Why Robinhood?

bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases. It also offers ZYNTEGLO or beti-cel and SKYSONA or eli-cel gene therapies. Show more

BLUE Key Statistics

bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases. It also offers ZYNTEGLO or beti-cel and SKYSONA or eli-cel gene therapies.